| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 3e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.27 | 6e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-07 |